Pharmacological inhibition in the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also referred to as FRAP-similar protein (FRP1)) has emerged being a promising technique for most cancers treatment that exploits synthetic lethal interactions with proteins linked to DNA injury fix, overcomes resistance to other therapies and boosts antitumour immunity. https://dominickzeimq.glifeblog.com/26369910/detailed-notes-on-deoxynivalenol